Vitamin Producing Lactic Acid Bacteria as Complementary Treatments for Intestinal Inflammation.

@article{deMorenodeLeBlanc2018VitaminPL,
  title={Vitamin Producing Lactic Acid Bacteria as Complementary Treatments for Intestinal Inflammation.},
  author={Alejandra de Moreno de LeBlanc and Romina Levit and Graciela Savoy de Giori and J. G. Leblanc},
  journal={Anti-inflammatory \& anti-allergy agents in medicinal chemistry},
  year={2018},
  volume={17 1},
  pages={
          50-56
        }
}
BACKGROUND Current therapies for against inflammatory bowel disease (IBD) are sometimes limited by high costs, high toxicities and/or undesirable side effects, reasons for which new treatments are constantly being developed and studied. In this regards, an increasing mass of data has demonstrated that fecal transplantations and probiotic supplementations have shown promising effects and could be considered as adjunct IBD treatments to decrease some of the unwanted side effects caused by primary… 

Immunobiosis and probiosis: antimicrobial activity of lactic acid bacteria with a focus on their antiviral and antifungal properties

The purpose of this review is to provide a fullest possible overview of the antiviral and antifungal activities ascribed to probiotic LAB.

Vitamin–Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis

New evidence suggests that oral vitamin supplementation can reduce inflammation levels and improve disease prognosis, and strategies to target gut-microbiota-dependent alterations in vitamin metabolism in the context of IBD and CAC therapy are highlighted.

Prophylactic Treatment with Vitamins C and B2 for Methotrexate-Induced Gastrointestinal Mucositis

Vitamins B2 and C enhanced anaerobic bacterial growth in vitro, however their ability to mitigate MTX-induced mucositis was limited, and in vivo administration of Vitamin C significantly attenuated clinical symptoms of mucosiositis.

A Role for Folate in Microbiome-Linked Control of Autoimmunity

It is proposed that one mechanism for microbiome-based control of AD/AID is via folate-dependent induction of GI tract Treg, particularly colonic Treg via anergic T cells (Tan), which has potential prophylactic and/or therapeutic benefit in AID/AD.

The Influence of Nutrients on Inflammatory Bowel Diseases

Properly selected nutrition might be an integral part of the treatment of patients with Crohn's disease or ulcerative colitis.

The Impact of Lactobacillus plantarum on the Gut Microbiota of Mice with DSS-Induced Colitis

Gut health was promoted by L. plantarum, as it diversified the microbes in the colon and restricted the activity of pathogenic bacteria in the intestine, according to the LEfSe analysis, which suggested that L. Plantarum improved the stability of the intestinal tract.

The Lactobacillus brevis 47 f Strain Protects the Murine Intestine from Enteropathy Induced by 5-Fluorouracil

The new lactobacilli strain attenuates the severity of 5 FU-induced enteropathy, and the ability of intestinal epitheliocytes to express Ki-67 was partially restored.

Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Gastroenterological Diseases in Adults

The clinical efficacy of probiotics depends on the probiotic strains included in their composition and is confirmed by a comparative analysis of the results of appropriate clinical studies.

Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults

Aim. The practical guidelines are intended for primary care physicians, general practitioners, paediatricians, gastroenterologists and general internists to advance the treatment and prevention of

The role of bacteria in the treatment of cancer: A comprehensive review

It is hoped that bacterial therapy will add a new dimension to cancer treatment due to the ineffectiveness of conventional treatments such as chemotherapy and radiation therapy in advanced tumor stages, resistance to treatment and non-specificity of these treatments.

References

SHOWING 1-10 OF 50 REFERENCES

Probiotics in Inflammatory Bowel Diseases and Cancer Prevention

Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases.

Evidence of probiotics in modulating vitamin D/VDR and balancing gut microbiota in health and gastrointestinal diseases is summarized and the limits and future direction in scientific understanding are discussed.

Bacteria as vitamin suppliers to their host: a gut microbiota perspective.

B‐Group vitamin production by lactic acid bacteria – current knowledge and potential applications

This review article will show the current knowledge of vitamin biosynthesis by LAB and show how the proper selection of starter cultures and probiotic strains could be useful in preventing clinical and subclinical vitamin deficiencies and in the elaboration of novel vitamin‐enriched products.

Evaluation of the effect of soymilk fermented by a riboflavin-producing Lactobacillus plantarum strain in a murine model of colitis.

This is the first report that demonstrates that a riboflavin-producing LAB was able to prevent experimental colitis in a murine model.

Goat whey ameliorates intestinal inflammation on acetic acid-induced colitis in rats.

It is suggested that goat whey exerted a preventive effect against the intestinal damage induced by acetic acid, showing a similar efficacy to that shown by sulfasalazine, therefore making it a potential treatment for human inflammatory bowel disease.

Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria

It is shown that these vitamins and SCFA producing bacteria could be used as tools to recover energy intakes by either optimizing ATP production from foods or by the fermentation of certain fibers in the gastrointestinal tract (GIT).

Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?

Increasing preclinical and clinical evidence suggests a role for vitamin D deficiency in the development and severity of IBD and the possible therapeutic role of vitamin D in patients with IBD merits continued investigation.

Folate Production by Probiotic Bacteria

The use of folate-producing probiotic strains could more efficiently confer protection against inflammation and cancer, both exerting the beneficial effects of probiotics and preventing the folate deficiency that is associated with premalignant changes in the colonic epithelia.